187
Views
1
CrossRef citations to date
0
Altmetric
Review

Current and emerging therapy of dry eye disease. Part B: non-pharmacological modalities

, , , , , , , & ORCID Icon show all
Pages 299-312 | Received 17 Nov 2016, Accepted 15 Jun 2017, Published online: 28 Jun 2017

References

  • The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye workshop (2007). Ocul Surf. 2007 Apr;5(2):93–107.
  • Nassiri N, Rodriguez Torres Y, Meyer Z, et al. Current and emerging therapy of dry eye disease. Part A: pharmacological modalities. Expert Rev Ophthalmol. 2017 May. Pages 1–29.
  • DeMartelaere SL, Blaydon SM, Tovilla-Canales JL, et al. A permanent and reversible procedure to block tear drainage for the treatment of dry eye. Ophthal Plast Reconstr Surg. 2006 Sep–Oct;22(5):352–355.
  • Dursun D, Ertan A, Bilezikçi B, et al. Ocular surface changes in keratoconjunctivitis sicca with silicone punctum plug occlusion. Curr Eye Res. 2003 May;26(5):263–269.
  • Gilbard JP, Rossi SR, Azar DT, et al. Effect of punctal occlusion by Freeman silicone plug insertion on tear osmolarity in dry eye disorders. CLAO J. 1989 Jul–Sep;15(3):216–218.
  • Yung YH, Toda I, Sakai C, et al. Punctal plugs for treatment of post-LASIK dry eye. Jpn J Ophthalmol. 2012 May;56(3):208–213.
  • Alfawaz AM, Algehedan S, Jastaneiah SS, et al. Efficacy of punctal occlusion in management of dry eyes after laser in situ keratomileusis for myopia. Curr Eye Res. 2014 Mar;39(3):257–262.
  • Giovagnoli D, Graham SJ. Inferior punctal occlusion with removable silicone punctal plugs in the treatment of dry-eye related contact lens discomfort. J Am Optom Assoc. 1992 Jul;63(7):481–485.
  • Geldis JR, Nichols JJ. The impact of punctal occlusion on soft contact lens wearing comfort and the tear film. Eye Contact Lens. 2008 Sep;34(5):261–265.
  • Rabensteiner DF, Boldin I, Klein A, et al. Collared silicone punctal plugs compared to intracanalicular plugs for the treatment of dry eye. Curr Eye Res. 2013 May;38(5):521–525.
  • Farrell J, Patel S, Grierson DG, et al. A clinical procedure to predict the value of temporary occlusion therapy in keratoconjunctivitis sicca. Ophthalmic Physiol Opt. 2003 Jan;23(1):1–8.
  • Miyata K, Otani S, Miyai T, et al. Atelocollagen punctal occlusion in dry eye patients. Cornea. 2006 Jan;25(1):47–50.
  • Hirai K, Takano Y, Uchio E, et al. Clinical evaluation of the therapeutic effects of atelocollagen absorbable punctal plugs. Clin Ophthalmol. 2012;6:133–138.
  • Hadassah J, Bhuvaneshwari N, Singh D, et al. Preparation and clinical evaluation of succinylated collagen punctal plugs in dry eye syndrome: a pilot study. Ophthalmic Res. 2010;43(4):185–192.
  • Altan-Yaycioglu R, Gencoglu EA, Akova YA, et al. Silicone versus collagen plugs for treating dry eye: results of a prospective randomized trial including lacrimal scintigraphy. Am J Ophthalmol. 2005 Jul;140(1):88–93.
  • Ohba E, Dogru M, Hosaka E, et al. Surgical punctal occlusion with a high heat-energy releasing cautery device for severe dry eye with recurrent punctal plug extrusion. Am J Ophthalmol. 2011 Mar;151(3):483–487.e481.
  • Capita L, Chalita MR, dos Santos-Neto LL. Prospective evaluation of hypromellose 2% for punctal occlusion in patients with dry eye. Cornea. 2015 Feb;34(2):188–192.
  • Egrilmez S, Aslan F, Karabulut G, et al. Clinical efficacy of the SmartPlug in the treatment of primary Sjogren’s syndrome with keratoconjunctivitis sicca: one-year follow-up study. Rheumatol Int. 2011 Dec;31(12):1567–1570.
  • Chen SX, Lee GA. SmartPlug in the management of severe dry eye syndrome. Cornea. 2007 Jun;26(5):534–538.
  • Burgess PI, Koay P, Clark P. SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trial. Cornea. 2008 May;27(4):391–394.
  • Brissette AR, Mednick ZD, Schweitzer KD, et al.. Punctal plug retention rates for the treatment of moderate to severe dry eye: a randomized, double-masked, controlled clinical trial. Am J Ophthalmol. 2015 Aug;160(2):238–242.e231.
  • Willis RM, Folberg R, Krachmer JH, et al. The treatment of aqueous-deficient dry eye with removable punctal plugs. A clinical and impression-cytologic study. Ophthalmology. 1987 May;94(5):514–518.
  • Sabti S, Halter JP, Braun Fränkl BC, et al. Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD. Bone Marrow Transplant. 2012 Jul;47(7):981–984.
  • Tong L, Beuerman R, Simonyi S, et al. Effects of punctal occlusion on clinical signs and symptoms and on tear cytokine levels in patients with dry eye. Ocul Surf. 2016 Apr;14(2):233–241.
  • Roberts CW, Carniglia PE, Brazzo BG. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye. Cornea. 2007 Aug;26(7):805–809.
  • Ozkan Y, Bozkurt B, Gedik S, et al. Corneal topographical study of the effect of lacrimal punctum occlusion on corneal surface regularity in dry eye patients. Eur J Ophthalmol. 2001;11(2):116–119.
  • Boldin I, Klein A, Haller-Schober E-M, et al. Long-term follow-up of punctal and proximal canalicular stenoses after silicone punctal plug treatment in dry eye patients. Am J Ophthalmol. 2008 Dec;146(6):968–972.e961.
  • Chen F, Shen M, Chen W, et al. Tear meniscus volume in dry eye after punctal occlusion. Invest Ophthalmol Vis Sci. 2010 Apr;51(4):1965–1969.
  • Qiu W, Liu Z, Zhang Z, et al. Punctal plugs versus artificial tears for treating dry eye: a comparative observation of their effects on contrast sensitivity. J Ocul Biol Dis Infor. 2012;5(1):19–24.
  • Ibrahim OM, Dogru M, Kojima T, et al. OCT assessment of tear meniscus after punctal occlusion in dry eye disease. Optom Vis Sci. 2012 May;89(5):E770–E776.
  • Qiu W, Liu Z, Ao M, et al. Punctal plugs versus artificial tears for treating primary Sjogren’s syndrome with keratoconjunctivitis SICCA: a comparative observation of their effects on visual function. Rheumatol Int. 2013 Oct;33(10):2543–2548.
  • Holzchuh R, Villa Albers MB, Osaki TH, et al. Two-year outcome of partial lacrimal punctal occlusion in the management of dry eye related to Sjogren syndrome. Curr Eye Res. 2011 Jun;36(6):507–512.
  • Benson DR, Hemmady PB, Snyder RW. Efficacy of laser punctal occlusion. Ophthalmology. 1992 Apr;99(4):618–621.
  • Liu D, Sadhan Y. Surgical punctal occlusion: a prospective study. Br J Ophthalmol. 2002 Sep;86(9):1031–1034.
  • Putterman AM. Canaliculectomy in the treatment of keratitis sicca. Ophthalmic Surg. 1991 Aug;22(8):478–480.
  • Murube-del-Castillo J, Hernandez-King J. Treatment of dry eye by moving the lacrimal punctum to dry dock. Ophthalmic Surg. 1993 Jan;24(1):53–58.
  • Murube J, Olivares C, Murube E. Treatment of dry eye by punctum patch. Orbit. 1995;14(1):1–7.
  • Vrabec MP, Elsing SH, Aitken PA. A prospective, randomized comparison of thermal cautery and argon laser for permanent punctal occlusion. Am J Ophthalmol. 1993 Oct 15;116(4):469–471.
  • Russo PA, Bouchard CS, Galasso JM. Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease. Eye Contact Lens. 2007 May;33(3):144–147.
  • Takahide K, Parker PM, Wu M, et al. Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2007 Sep;13(9):1016–1021.
  • Li J, Zhang X, Zheng Q, et al. Comparative evaluation of silicone hydrogel contact lenses and autologous serum for management of sjogren syndrome-associated dry eye. Cornea. 2015 Sep;34(9):1072–1078.
  • Alipour F, Kheirkhah A, Jabarvand Behrouz M. Use of mini scleral contact lenses in moderate to severe dry eye. Cont Lens Anterior Eye. 2012 Dec;35(6):272–276.
  • Yuksel E, Bilgihan K, Novruzlu S, et al. The management of refractory dry eye with semi-scleral contact lens. Eye Contact Lens. 2016 May 19. [Epub ahead of print].
  • Schornack MM, Baratz KH, Patel SV, et al. Jupiter scleral lenses in the management of chronic graft versus host disease. Eye Contact Lens. 2008 Nov;34(6):302–305.
  • Kok JH, Visser R. Treatment of ocular surface disorders and dry eyes with high gas-permeable scleral lenses. Cornea. 1992 Nov;11(6):518–522.
  • McDonald M, D’Aversa G, Perry HD, et al. Hydroxypropyl cellulose ophthalmic inserts (lacrisert) reduce the signs and symptoms of dry eye syndrome and improve patient quality of life. Trans Am Ophthalmol Soc. 2009;107:214–221.
  • McDonald M, D’Aversa G, Perry HD, et al. Correlating patient-reported response to hydroxypropyl cellulose ophthalmic insert (LACRISERT®) therapy with clinical outcomes: tools for predicting response. Curr Eye Res. 2010 Oct;35(10):880–887.
  • Hill JC. Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis. Br J Ophthalmol. 1989 Feb;73(2):151–154.
  • Wander AH. Long-term use of hydroxypropyl cellulose ophthalmic insert to relieve symptoms of dry eye in a contact lens wearer: case-based experience. Eye Contact Lens. 2011 Jan;37(1):39–44.
  • Wander AH, Koffler BH. Extending the duration of tear film protection in dry eye syndrome: review and retrospective case series study of the hydroxypropyl cellulose ophthalmic insert. Ocul Surf. 2009 Jul;7(3):154–162.
  • Koffler BH, McDonald M, Nelinson DS, et al. Improved signs, symptoms, and quality of life associated with dry eye syndrome: hydroxypropyl cellulose ophthalmic insert patient registry. Eye Contact Lens. 2010 May;36(3):170–176.
  • Bilkhu PS, Naroo SA, Wolffsohn JS. Randomised masked clinical trial of the MGDRx EyeBag for the treatment of meibomian gland dysfunction-related evaporative dry eye. Br J Ophthalmol. 2014 Dec;98(12):1707–1711.
  • Sim HS, Petznick A, Barbier S, et al.. A randomized, controlled treatment trial of eyelid-warming therapies in meibomian gland dysfunction. Ophthalmol Ther. 2014 Dec;3(1–2):37–48.
  • Wang MT, Jaitley Z, Lord SM, et al. Comparison of self-applied heat therapy for meibomian gland dysfunction. Optom Vis Sci. 2015 Sep;92(9):e321–e326.
  • Mori A, Shimazaki J, Shimmura S, et al. Disposable eyelid-warming device for the treatment of meibomian gland dysfunction. Jpn J Ophthalmol. 2003 Nov–Dec;47(6):578–586.
  • Benitez Del Castillo JM, Kaercher T, Mansour K, et al. Evaluation of the efficacy, safety, and acceptability of an eyelid warming device for the treatment of meibomian gland dysfunction. Clin Ophthalmol. 2014;8:2019–2027.
  • Villani E, Garoli E, Canton V, et al. Evaluation of a novel eyelid-warming device in meibomian gland dysfunction unresponsive to traditional warm compress treatment: an in vivo confocal study. Int Ophthalmol. 2015 Jun;35(3):319–323.
  • Lane SS, DuBiner HB, Epstein RJ, et al. A new system, the LipiFlow, for the treatment of meibomian gland dysfunction. Cornea. 2012 Apr;31(4):396–404.
  • Zhao Y, Veerappan A, Yeo S, et al. Clinical trial of thermal pulsation (LipiFlow) in meibomian gland dysfunction with preteatment meibography. Eye Contact Lens. 2016 Nov;42(6):339–346.
  • Finis D, König C, Hayajneh J, et al. Six-month effects of a thermodynamic treatment for MGD and implications of meibomian gland atrophy. Cornea. 2014 Dec;33(12):1265–1270.
  • Greiner JV. A single LipiFlow® thermal pulsation system treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Curr Eye Res. 2012 Apr;37(4):272–278.
  • Greiner JV. Long-term (12-month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment. Clin Exp Ophthalmol. 2013 Aug;41(6):524–530.
  • Greiner JV. Long-term (3 year) effects of a single thermal pulsation system treatment on meibomian gland function and dry eye symptoms. Eye Contact Lens. 2016 Mar;42(2):99–107.
  • Yeo S, Tan JH, Acharya UR, et al.. Longitudinal changes in tear evaporation rates after eyelid warming therapies in meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):1974–1981.
  • Lee J-E, Kim NM, Yang JW, et al. A randomised controlled trial comparing a thermal massager with artificial teardrops for the treatment of dry eye. Br J Ophthalmol. 2014 Jan;98(1):46–51.
  • Finis D, Hayajneh J, König C, et al. Evaluation of an automated thermodynamic treatment (LipiFlow®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Ocul Surf. 2014 Apr;12(2):146–154.
  • Satjawatcharaphong P, Ge S, Lin MC. Clinical outcomes associated with thermal pulsation system treatment. Optom Vis Sci. 2015 Sep;92(9):e334–e341.
  • Toyos R, McGill W, Briscoe D. Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study. Photomed Laser Surg. 2015 Jan;33(1):41–46.
  • Vegunta S, Patel D, Shen JF. Combination therapy of intense pulsed light therapy and meibomian gland expression (IPL/MGX) can improve dry eye symptoms and meibomian gland function in patients with refractory dry eye: a retrospective analysis. Cornea. 2016 Mar;35(3):318–322.
  • Craig JP, Chen Y-H, Turnbull PR. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2015 Feb 12; 56(3):1965–1970.
  • Jeon J-H, Shin M-S, Lee MS, et al. Acupuncture reduces symptoms of dry eye syndrome: a preliminary observational study. J Altern Complement Med. 2010 Dec;16(12):1291–1294.
  • Grönlund MA, Stenevi U, Lundeberg T. Acupuncture treatment in patients with keratoconjunctivitis sicca: a pilot study. Acta Ophthalmol Scand. 2004 Jun;82(3 Pt 1):283–290.
  • Kim T-H, Kang JW, Kim KH. Acupuncture for the treatment of dry eye: a multicenter randomised controlled trial with active comparison intervention (artificial teardrops). PLoS One. 2012;7(5):e36638.
  • Tseng K-L, Liu H-J, Tso K-Y, et al. A clinical study of acupuncture and SSP (silver spike point) electro-therapy for dry eye syndrome. Am J Chin Med. 2006;34(2):197–206.
  • Shin M-S, Kim J-I, Lee MS, et al. Acupuncture for treating dry eye: a randomized placebo-controlled trial. Acta Ophthalmol. 2010 Dec;88(8):e328–e333.
  • Lin T, Gong L, Liu X, et al. Fourier-domain optical coherence tomography for monitoring the lower tear meniscus in dry eye after acupuncture treatment. Evid Based Complement Alternat Med. 2015;2015:492150.
  • Yang L, Yang Z, Yu H, et al. Acupuncture therapy is more effective than artificial tears for dry eye syndrome: evidence based on a meta-analysis. Evid Based Complement Alternat Med. 2015;2015:143858.
  • Maskin SL. Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction. Cornea. 2010 Oct;29(10):1145–1152.
  • Nakayama N, Kawashima M, Kaido M, et al. Analysis of meibum before and after intraductal meibomian gland probing in eyes with obstructive meibomian gland dysfunction. Cornea. 2015 Oct;34(10):1206–1208.
  • Sik Sarman Z, Cucen B, Yuksel N, et al. Effectiveness of intraductal meibomian gland probing for obstructive meibomian gland dysfunction. Cornea. 2016 Jun;35(6):721–724.
  • Ma X, Lu Y. Efficacy of intraductal meibomian gland probing on tear function in patients with obstructive meibomian gland dysfunction. Cornea. 2016 Jun;35(6):725–730.
  • Tsubota K. The effect of wearing spectacles on the humidity of the eye. Am J Ophthalmol. 1989 Jul 15;108(1):92–93.
  • Korb DR, Greiner JV, Glonek T, et al. Effect of periocular humidity on the tear film lipid layer. Cornea. 1996 Mar;15(2):129–134.
  • Waduthantri S, Tan CH, Fong YW, et al. Specialized moisture retention eyewear for evaporative dry eye. Curr Eye Res. 2015 May;40(5):490–495.
  • Shen G, Qi Q, Ma X. Effect of moisture chamber spectacles on tear functions in dry eye disease. Optom Vis Sci. 2016 Feb;93(2):158–164.
  • Tsubota K, Yamada M, Urayama K. Spectacle side panels and moist inserts for the treatment of dry-eye patients. Cornea. 1994 May;13(3):197–201.
  • Cosar CB, Cohen EJ, Rapuano CJ, et al. Tarsorrhaphy: clinical experience from a cornea practice. Cornea. 2001 Nov;20(8):787–791.
  • Su J-Z, Cai Z-G, Yu G-Y. Microvascular autologous submandibular gland transplantation in severe cases of keratoconjunctivitis sicca. Maxillofac Plast Reconstr Surg. 2015 Dec;37(1):5.
  • Borrelli M, Schröder C, Dart JK, et al. Long-term follow-up after submandibular gland transplantation in severe dry eyes secondary to cicatrizing conjunctivitis. Am J Ophthalmol. 2010 Dec;150(6):894–904.
  • Yu GY, Zhu ZH, Mao C, et al. Microvascular autologous submandibular gland transfer in severe cases of keratoconjunctivitis sicca. Int J Oral Maxillofac Surg. 2004 Apr;33(3):235–239.
  • Geerling G, Sieg P, Bastian G-O, et al. Transplantation of the autologous submandibular gland for most severe cases of keratoconjunctivitis sicca. Ophthalmology. 1998;105(2):327–335.
  • Jacobsen H-C, Hakim SG, Lauer I, et al. Long-term results of autologous submandibular gland transfer for the surgical treatment of severe keratoconjunctivitis sicca. J Craniomaxillofac Surg. 2008 Jun;36(4):227–233.
  • Qin J, Zhang L, Cai Z-G, et al. Microvascular autologous transplantation of partial submandibular gland for severe keratoconjunctivitis sicca. Br J Ophthalmol. 2013 Sep;97(9):1123–1128.
  • Marinho DR, Burmann TG, Kwitko S. Labial salivary gland transplantation for severe dry eye due to chemical burns and Stevens-Johnson syndrome. Ophthal Plast Reconstr Surg. 2010 May–Jun;26(3):182–184.
  • Sant’ Anna AE, Hazarbassanov RM, de Freitas D, et al. Minor salivary glands and labial mucous membrane graft in the treatment of severe symblepharon and dry eye in patients with Stevens-Johnson syndrome. Br J Ophthalmol. 2012 Feb;96(2):234–239.
  • Güerrissi JO, Belmonte J. Surgical treatment of dry eye syndrome: conjunctival graft of the minor salivary gland. J Craniofac Surg. 2004 Jan;15(1):6–10.
  • Cheng AM, Zhao D, Chen R, et al. Accelerated restoration of ocular surface health in dry eye disease by self-retained cryopreserved amniotic membrane. Ocul Surf. 2016 Jan;14(1):56–63.
  • Hamano T. Lacrimal duct occlusion for the treatment of dry eye. Semin Ophthalmol. 2005 Apr–Jun;20(2):71–74.
  • Ervin A-M, Wojciechowski R, Schein O. Punctal occlusion for dry eye syndrome. Cochrane Database Syst Rev. 2010 Sep 8;(9):CD006775.
  • Bourkiza R, Lee V. A review of the complications of lacrimal occlusion with punctal and canalicular plugs. Orbit. 2012 Apr;31(2):86–93.
  • Beisel JG. Treatment of dry eye with punctal plugs. Optom Clin. 1991;1(4):103–117.
  • Foulks GN, Forstot SL, Donshik PC, et al. Clinical guidelines for management of dry eye associated with Sjogren disease. Ocul Surf. 2015 Apr;13(2):118–132.
  • Punctal occlusion for the dry eye. Three-year revision. American Academy of Ophthalmology. Ophthalmology. 1997 Sep;104(9):1521–1524.
  • Geerling G, Tost FH. Surgical occlusion of the lacrimal drainage system. Dev Ophthalmol. 2008;41:213–229.
  • Murube J, Murube E. Treatment of dry eye by blocking the lacrimal canaliculi. Surv Ophthalmol. 1996 May–Jun;40(6):463–480.
  • Healthy Contact Lens Wear and Care. Fast facts. Center for Disease Control and Prevention. [Cited 2017 Feb 15]. Available from: https://www.cdc.gov/contactlenses/fast-facts.html - one
  • Riley C, Young G, Chalmers R. Prevalence of ocular surface symptoms, signs, and uncomfortable hours of wear in contact lens wearers: the effect of refitting with daily-wear silicone hydrogel lenses (senofilcon A). Eye Contact Lens. 2006 Dec;32(6):281–286.
  • Keir N, Woods CA, Dumbleton K, et al. Clinical performance of different care systems with silicone hydrogel contact lenses. Cont Lens Anterior Eye. 2010 Aug;33(4):189–195.
  • Ousler GW 3rd, Anderson RT, Osborn KE. The effect of senofilcon A contact lenses compared to habitual contact lenses on ocular discomfort during exposure to a controlled adverse environment. Curr Med Res Opin. 2008 Feb;24(2):335–341.
  • Bavinger JC, DeLoss K, Mian SI. Scleral lens use in dry eye syndrome. Curr Opin Ophthalmol. 2015 Jul;26(4):319–324.
  • Dimit R, Gire A, Pflugfelder SC, et al. Patient ocular conditions and clinical outcomes using a PROSE scleral device. Cont Lens Anterior Eye. 2013 Aug;36(4):159–163.
  • Nguyen T, Latkany R. Review of hydroxypropyl cellulose ophthalmic inserts for treatment of dry eye. Clin Ophthalmol. 2011;5:587–591.
  • Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf. 2004 Apr;2(2):149–165.
  • Olson MC, Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction. Eye Contact Lens. 2003 Apr;29(2):96–99.
  • Wang MT, Gokul A, Craig JP. Temperature profiles of patient-applied eyelid warming therapies. Cont Lens Anterior Eye. 2015 Dec;38(6):430–434.
  • Vora GK, Gupta PK. Intense pulsed light therapy for the treatment of evaporative dry eye disease. Curr Opin Ophthalmol. 2015 Jul;26(4):314–318.
  • Lee MS, Shin B-C, Choi T-Y, et al. Acupuncture for treating dry eye: a systematic review. Acta Ophthalmol. 2011 Mar;89(2):101–106.
  • Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea. 2008 Dec;27(10):1142–1147.
  • Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment of meibomian gland dysfunction. AAdv Exp Med Biol. 1994;350:293–298.
  • Korb DR, Blackie CA. Meibomian gland therapeutic expression: quantifying the applied pressure and the limitation of resulting pain. Eye Contact Lens. 2011 Sep;37(5):298–301.
  • Qiao J, Yan X. Emerging treatment options for meibomian gland dysfunction. Clin Ophthalmol. 2013;7:1797–1803.
  • Management and therapy of dry eye disease: report of the management and therapy subcommittee of the international dry eye workshop (2007). Ocul Surf. 2007 Apr;5(2):163–178.
  • Alex A, Edwards A, Hays JD, et al.. Factors predicting the ocular surface response to desiccating environmental stress. Invest Ophthalmol Vis Sci. 2013 May 7;54(5):3325–3332.
  • Hart DE, Simko M, Harris E. How to produce moisture chamber eyeglasses for the dry eye patient. J Am Optom Assoc. 1994 Jul;65(7):517–522.
  • Valim V, Trevisani VF, de Sousa JM, et al. Current approach to dry eye disease. Clin Rev Allergy Immunol. 2015 Dec;49(3):288–297.
  • Geerling G, Honnicke K, Schröder C, et al. Quality of salivary tears following autologous submandibular gland transplantation for severe dry eye. Graefes Arch Clin Exp Ophthalmol. 2000 Jan;238(1):45–52.
  • Lauer I, Sieg P, Bähre M, et al. Salivary gland scintigraphy using technetium-99m-pertechnetate after autotransplantation of the submandibular salivary gland in the correction of dry eye. Eur J Nucl Med Mol Imaging. 1998;25(2):128–131.
  • Zhang L, Zhu Z-H, Dai H-J, et al. Application of 99mTc-pertechnetate scintigraphy to microvascular autologous transplantation of the submandibular gland in patients with severe keratoconjunctivitis sicca. J Nucl Med. 2007 Sep;48(9):1431–1435.
  • Shay E, Kheirkhah A, Liang L, et al. Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis. Surv Ophthalmol. 2009 Nov–Dec;54(6):686–696.
  • Dua HS, Gomes JA, King AJ, et al. The amniotic membrane in ophthalmology. Surv Ophthalmol. 2004 Jan–Feb;49(1):51–77.
  • Friedman NJ, Butron K, Robledo N, et al. A nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease. Clin Ophthalmol. 2016;10:795–804.
  • Patane MA, Cohen A, From S, et al. Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial. Clin Ophthalmol. 2011;5:633–643.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.